Daniel R. Chevallard - Insider Trading & Ownership

Entity
Individual
Location
C/O Regulus Therapeutics Inc., 10614 Science Center Drive, San Diego, CA
Summary
The estimated net worth of Daniel R. Chevallard is at least $98.5K dollars as of May 15, 2024. Daniel R. Chevallard is the CFO and COO of Viracta Therapeutics, Inc. and owns shares of Viracta Therapeutics, Inc. (VIRX) stock worth about $91.9K. Daniel R. Chevallard is the Chief Financial Officer of LENZ Therapeutics, Inc. and owns shares of LENZ Therapeutics, Inc. (LENZ) stock worth about $6.63K.
All Insider Reports
All Insider Reports

Ownership of Daniel R. Chevallard

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VIRX Viracta Therapeutics, Inc. CFO and COO $91.9K -$2.49K -2.64% Mar 12, 2024
LENZ LENZ Therapeutics, Inc. Chief Financial Officer $6.63K May 14, 2024

Insider Transactions Reported by Daniel R. Chevallard:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.